NCT07505745 Phase 2a Trial: MOTS-c Insulin Sensitivity Research Data NCT07505745 is a Phase 2a trial testing MOTS-c in 120 prediabetic adults, targeting insulin sensitivity via the Matsuda Index over 12 weeks
Results For child-caregiver agreement (aim 1), 227 child-caregiver dyads completed the PROMIS Pain Interference, Mobility, Upper Extremity item banks and legacy instruments
If youre curious about taking a GLP-1 for PCOS, have a conversation with your doctor who can talk you through side effects , contraindications, and if its a good fit for your treatment plan, says Dr
Glucagon-like peptide-1 increases myocardial glucose uptake via p38alpha MAP kinase-mediated, nitric oxide-dependent mechanisms in conscious dogs with dilated cardiomyopathy
Investors are asking senior business leaders to describe the impact GLP-1RAs may have on their business and the strategic changes required to respond
This means dosage calculations depend on both the vial strength and dilution volume
